Clinical Trials · NCT00175305

Prader-Willi Syndrome and Appetite

TerminatedPhase 3Octreotide (Prohibited)
Phase
Phase 3
Recruitment status
Terminated
Sponsor
University of British Columbia
Enrollment
10
Start date
Aug 2004
Locations
1 site, Canada
Primary endpoint
Changes in ghrelin concentrations during a test meal
View Octreotide compound reference